The mutual exclusivity of EGFR amplification and KRAS mutations has been described in lung adenocarcinoma and colorectal carcinoma (CRC) and co-expression caused cytotoxic effect on cells39,40. This evidence concerns the gene KRAS and colorectal carcinoma.